Pharmaceutical Interventions
-
377Innovation and Creativity Can Help Grow Myopia Management Practices
September 15, 2021 By Michael Dittman, OD; Dittman Eyecare, Butler, PA My associate doctors and I do our best to educate parents...
-
441Developing New Anti-Myopia Drugs
September 15, 2021 By Andrei V. Tkatchenko, MD, PhD, and Tatiana V. Tkatchenko, MD The development of effective and safe drugs for...
-
1.8KPutting in the Work for Myopia Management Benefits Young Patients
August 16, 2021 By Katherine Schuetz, OD; RevolutionEYES and Little Eyes Pediatric Eye Care, Carmel, IN As our profession learns to embrace...
-
1.7KCase in Point
August 2, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Several products and interventions — which have been proposed for reducing the...
-
3.5KSpectacle Lenses for Myopia Management Changed Our Practice
August 2, 2021 By Vishakha Thakrar, OD; Vaughan Family Vision Care, Ontario, Canada Since we started utilizing novel spectacle lenses, we have...
-
1.9KStarting Myopia Management Early Yields Greatest Outcomes
July 15, 2021 By Melanie Frogozo, OD, FAAO, Alamo Eye Care , San Antonio, Texas To give children the greatest chance of...
-
6.0KMechanism of Action of Atropine in Controlling Myopia Progression
October 1, 2020 By Huy Tran, MD, and Thao Ha, MD Myopia is the most common refractive error worldwide and is estimated...
-
7.4KTopical Low-Dose Atropine: A Global Perspective
June 24, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA Chief Medical Editor, Review of Myopia Management The use of atropine to...
-
3.9KEyenovia Developing a Microdose Treatment for Delivering Atropine
June 12, 2020 The clinical-stage ophthalmic biopharmaceutical company Eyenovia is developing a microdose treatment that is designed to improve the delivery of...
-
6.9KOne Drop into Each Eye at Bedtime: What Could be Simpler?
May 1, 2020 By Laura Kirkeby, CO The use of atropine has been known to slow the progression of myopia for many...
-
2.5KWhat is the Optimal Concentration of Topical Low-dose Atropine?
April 1, 2020 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management Topical low-dose atropine is an...
-
7.6KRecommendations for Tapering Long-term Use of Topical Low-dose Atropine
There are two strategies to consider for stopping atropine treatment.
-
4.2KCochrane Systematic Review of Myopia Interventions
March 1, 2020 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management To assess the effects of interventions...
-
9.9KCombination Strategies – What is Their Role in Myopia Management?
Individual interventions may not result in the expected efficacy.
-
Interventions for Controlling Myopia Onset and Progression Report
This summary of an International Myopia Institute (IMI) white paper was created by and is used with permission from the Centre for...
-
2.3KWhat’s New with Pharmaceutical Interventions for Myopia
Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
-
5.7KEfficacy and Safety of 0.01% Atropine in Myopic Children With European Ancestry
The researchers concluded that topical low-dose atropine appears to be safe and effective in a cohort of European schoolchildren.
-
3.8K
Low-Concentration Atropine for Myopia Progression (LAMP)
A summary of the LAMP Study results
-
2.5K
Orthokeratology, low-dose atropine and axial elongation
Axial elongation rate is faster in younger children undergoing ortho-k treatment.
-
6.6K
Topical Atropine for Myopia Management: The Latest Research
When should one start atropine treatment for myopes?
